With regards to the gel not using the thermalife formulation I would suggest its because the company wants to reach out to the cheaper end of the market for muscle pain. by not using the peptide production costs would be much less.
For it to sell it would need to offer something new. There are already enough such products.
the pno story, page-6
Add CAI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $93.67M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| CAI (ASX) Chart |
Day chart unavailable